Deploy AI on real clinical data in weeks, not years. Our automated pipelines scrub PHI from text, images, and structured data, creating HIPAA-compliant, research-ready datasets that preserve analytical utility.
Service
Architecture review before implementation
Implementation scope and rollout planning
Clear next-step recommendation
Automated, auditable de-identification of Protected Health Information (PHI) to enable safe AI research and development.
Deploy AI on real clinical data in weeks, not years. Our automated pipelines scrub PHI from text, images, and structured data, creating HIPAA-compliant, research-ready datasets that preserve analytical utility.
spaCy and custom NER models.Move from data lockdown to innovation. Securely fuel your Clinical Decision Support and Ambient AI projects, Medical Imaging models, and Predictive Analytics engines with compliant, actionable data. Explore our related services for Clinical NLP Pipeline Engineering and Healthcare AI Compliance and Governance Consulting.
Our HIPAA-compliant de-identification pipelines transform sensitive clinical data from a liability into a secure, reusable asset for AI research and development, unlocking innovation while ensuring patient privacy.
Deploy custom NLP models trained on medical terminology to automatically identify and redact 18 HIPAA identifiers from clinical text, DICOM headers, and structured EHR data with >99% accuracy, eliminating manual review.
Engineer pipelines that meet both HIPAA Safe Harbor standards and the statistical Expert Determination method, providing legally defensible de-identification with full audit trails and re-identification risk assessments below 0.09%.
Rapidly provision clean, analysis-ready datasets for internal R&D teams and external research collaborations, reducing data preparation time from months to days and accelerating time-to-insight for clinical AI projects.
Create new revenue streams by safely licensing de-identified, high-value clinical datasets to pharmaceutical companies, medical device developers, and academic institutions, turning compliance cost centers into profit centers.
Our proven, phased methodology ensures a compliant, production-ready de-identification pipeline in under two months, minimizing disruption to your existing workflows.
| Phase | Duration | Key Activities | Deliverables |
|---|---|---|---|
Week 1-2: Discovery & Assessment | 2 Weeks | HIPAA gap analysis, data source inventory, PHI classification audit, stakeholder interviews | Compliance roadmap, technical architecture proposal, project charter |
Week 3-4: Pipeline Design & Development | 2 Weeks | Custom NER model tuning, synthetic data generation for testing, pipeline integration design | Core de-identification engine, integration API specifications, initial validation report |
Week 5-6: Validation & Integration | 2 Weeks | Rigorous testing on sample datasets, performance benchmarking, pilot integration with one data source | Validation report (>99.5% recall), integrated pilot system, operational runbook |
Week 7-8: Staging & Production Rollout | 2 Weeks | Full-scale deployment, staff training, monitoring dashboard setup, final security review | Production-ready system, training materials, 99.9% uptime SLA, ongoing support plan |
Ongoing: Support & Optimization | Continuous | Performance monitoring, model retraining, compliance updates (e.g., new HIPAA guidance) | Monthly performance reports, optional managed service for updates |
Our clinical data de-identification services unlock the value of sensitive health data for AI innovation. By implementing automated, auditable pipelines, we enable healthcare organizations and technology partners to develop and train advanced models—from ambient documentation to predictive analytics—without compromising patient privacy or regulatory compliance.
Create fully de-identified, HIPAA-compliant datasets for training and validating novel AI models. We enable safe access to real-world clinical data, accelerating the development of diagnostic algorithms, treatment recommendation engines, and patient risk predictors without the legal and ethical risks of using raw PHI.
Securely share patient cohort data between research institutions, CROs, and pharmaceutical partners. Our pipelines anonymize structured EHR data and unstructured clinical notes, enabling collaborative analysis and federated learning initiatives while maintaining strict participant confidentiality and audit trails.
Safely provide healthcare data to external analytics platforms, business intelligence tools, or software vendors. We de-identify data feeds in real-time or batch processes, allowing partners to deliver insights and services—like population health analytics or operational benchmarking—without ever handling identifiable information.
Contribute to national registries, public health research, or quality improvement initiatives. We ensure data submitted to repositories like CDC or academic consortia is rigorously de-identified, meeting publication and sharing standards while preserving the statistical utility needed for meaningful epidemiological and outcomes research.
Enabling Efficiency, Speed & Accuracy
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Get specific answers on how we build automated, secure systems to de-identify Protected Health Information (PHI) for safe AI research and development.
We implement a multi-layered, automated pipeline combining Named Entity Recognition (NER) models specifically fine-tuned on clinical text (e.g., spaCy Healthcare, BioBERT), deterministic pattern matching for PHI like dates and IDs, and context-aware redaction. All pipelines are built with a human-in-the-loop validation step and are designed to meet the "Safe Harbor" and "Expert Determination" methods under HIPAA. Our process is documented and repeatable for audit purposes.
About the author
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
How We Work
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
The first call is a practical review of your use case and the right next step.
